Iovance Biotherapeutics Sets Third-Quarter Results Call
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
West Pharma Executive Says CGM Program Decline Contributed to Q3 Revenue Drop
A West Pharma executive said a decline in the CGM program contributed to a Q3 revenue drop at West Vantage.
M impact | EQUITY | Oct 29, 2026, 12:18 PM UTC
Shira Real Estate Development and Investments Reports Q3 Loss of 112,814 Dinars
M impact | EQUITY | Oct 29, 2026, 12:18 PM UTC
Arab Aluminium Industry Reports Q3 Profit of 6,093 Dinars
M impact | EQUITY | Oct 29, 2026, 12:18 PM UTC
Quanome Technologies Enters Second GPU Server Purchase Agreement
Quanome Technologies entered a second purchase agreement for 32 GPU server units at $18.80 million.
L impact | EQUITY | Oct 29, 2026, 12:18 PM UTC
Silicom Reports Q3 Revenue of $26.7M, Adjusted EPS of $0.04
M impact | EQUITY | Oct 29, 2026, 12:18 PM UTC
Shengyi Electronics Says Q3 Revenue Rose 23% Year Over Year
M impact | EQUITY | Oct 29, 2026, 12:18 PM UTC